Documente Academic
Documente Profesional
Documente Cultură
Clostridium perfringens Type A is an emerging disease that’s being reported with increasing
frequency by diagnostic laboratories. In response to the need for a vaccine, Novartis Animal
Health US, Inc. created the first-ever conditionally licensed C. perfringens Type A vaccine for
cattle – Clostridium Perfringens Type A Toxoid. Following are answers to some of the most
frequently asked questions about this disease and this new preventative option.
1. Bueschel DM, et al. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens Type A alpha toxin in dairy calves fed colostrum
Clostridium perfringens field isolates: correlation of genotype with pheno- from immunized dams. Paper presented at Annual Meeting of American
type. Vet Microbiol. 2003;94(2):121-9. Association of Bovine Practitioners. 2006. Saint Paul, Minnesota.
2. Van Metre D, et. al. Passive transfer of neutralizing antibodies to 3. Data on file, Novartis Animal Health US, Inc.